The Cornell Tech Council, the primary governance group for Cornell Tech and a subsidiary body of the Cornell University Board of Trustees, has announced the appointment of Howard Morgan Ph.D. ’68 as its new chairman and Adam…
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, according to researchers at Weill Cornell Medicine and University at Buffalo.
For his support in helping the Cornell Program in Infrastructure Policy access critical funding in his role as vice provost, Emmanuel Giannelis received the program's annual award during a ceremony in New York City.
Experts’ more stringent online reviews have the effect of compressing aggregate ratings by penalizing higher-quality products compared to their lower-quality alternatives. To address this problem, a research team developed a method for de-biasing ratings.
Weill Cornell Medicine and Weill Bugando School of Medicine collaborate to strengthen medical education, health care and innovative global health research at both institutions.
Weill Cornell Medicine researchers have discovered a mechanism that ovarian tumors use to cripple immune cells – blocking the energy supply T cells depend on. The work points toward a promising new immunotherapy approach for ovarian cancer.
Nicola Dell, associate professor at the Jacobs Technion-Cornell Institute at Cornell Tech, and novelist Ling Ma, MFA ’16, have been awarded 2024 MacArthur Foundation fellowships — more commonly known as “genius grants.”
Investigators from Weill Cornell Medicine have discovered a defense mechanism that protects skin cancer cells from oxidative stress and helps them spread.
A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.